Old Web
English
Sign In
Acemap
>
authorDetail
>
Yankun Duan
Yankun Duan
Central South University
Proto-oncogene tyrosine-protein kinase Src
Chemistry
High-mobility group
Cancer research
Hepatocellular carcinoma
5
Papers
71
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases.
2021
Bioorganic & Medicinal Chemistry Letters
Ming Guo
Shuyan Dai
Daichao Wu
Yankun Duan
Jun Li
Lingzhi Qu
Longying Jiang
Zhuchu Chen
Xiaojuan Chen
Yongheng Chen
Show All
Source
Cite
Save
Citations (0)
Remarkably Stereospecific Utilization of ATP α,β-Halomethylene Analogues by Protein Kinases
2017
Journal of the American Chemical Society
Feng Ni
Alvin Kung
Yankun Duan
Vivek Shah
Carolina D. Amador
Ming Guo
Xue-Gong Fan
Lin Chen
Yongheng Chen
Charles E. McKenna
Chao Zhang
Show All
Source
Cite
Save
Citations (10)
c-Src binds to the cancer drug Ruxolitinib with an active conformation.
2014
PLOS ONE
Yankun Duan
Lin Chen
Yongheng Chen
Xue-Gong Fan
Show All
Source
Cite
Save
Citations (19)
Reduced High-Mobility Group Box 1 Expression Induced by RNA Interference Inhibits the Bioactivity of Hepatocellular Carcinoma Cell Line HCCLM3
2012
Digestive Diseases and Sciences
Wei Jiang
Zhiming Wang
Xinying Li
Jindong Li
Yun Huang
Xue-Gong Fan
Yankun Duan
Show All
Source
Cite
Save
Citations (15)
High-mobility group box 1 is associated with clinicopathologic features in patients with hepatocellular carcinoma.
2012
Pathology & Oncology Research
Wei Jiang
Zhiming Wang
Xinying Li
Xuegong Fan
Yankun Duan
Show All
Source
Cite
Save
Citations (27)
1